Alyeska Investment Group, L.P. - LIANBIO ownership

LIANBIO's ticker is and the CUSIP is 53000N108. A total of 45 filers reported holding LIANBIO in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
Alyeska Investment Group, L.P. ownership history of LIANBIO
ValueSharesWeighting
Q3 2022$858,000
+20.7%
429,186
+30.4%
0.01%
+25.0%
Q2 2022$711,000
-43.5%
329,186
-3.0%
0.01%
-42.9%
Q1 2022$1,259,000
-28.3%
339,242
+19.1%
0.01%
-30.0%
Q4 2021$1,755,000284,8500.02%
Other shareholders
LIANBIO shareholders Q3 2022
NameSharesValueWeighting ↓
Vida Ventures Advisors, LLC 2,282,084$4,929,0004.16%
Perceptive Advisors 56,560,211$122,170,0003.83%
SCHF (GPE), LLC 937,500$2,025,0002.99%
VR Adviser, LLC 5,378,341$11,617,0002.29%
TYBOURNE CAPITAL MANAGEMENT (HK) LTD 3,314,173$7,159,0000.52%
Affinity Asset Advisors, LLC 450,000$972,0000.41%
Altium Capital Management LP 315,191$681,0000.27%
RA Capital Management 4,622,574$9,985,0000.27%
22NW, LP 141,223$305,0000.16%
Logos Global Management LP 394,486$852,0000.16%
View complete list of LIANBIO shareholders